Understanding our eugenic past to take steps towards scientific accountability
By Rori Rohlfs,
Genes to Genomes
| 06. 08. 2020
Because genetic determinism is an implicit and stealth component of our academic inheritance, even well-meaning scientists working at respected institutions can unwittingly pursue research that supports eugenicist arguments.
I was a fourth-year graduate student when I found myself asking a librarian for the archives of the journal The Annals of Eugenics. I got to that point by climbing back through a chain of references on fundamental statistical measures in my field of population genetics. I held the journal and flipped through the article titles and familiar author names, realizing that my field wasn’t so far removed from the turn-of-the-century eugenics movement. Feeling somewhat nauseous, I photocopied the article I was looking for and returned the journal quickly.
Now as a faculty member at San Francisco State University (SFSU), a public institution that puts social justice at the center of its mission, I continue to struggle with my field’s limited reckoning with our eugenic past. Can folks like me, who have built careers that grow from eugenics science, hold ourselves accountable for these roots as we continue scientific research? These questions become increasingly important in a political landscape where scientific ideas about genetic variation and difference are weaponized to support devastating policies, and the atrocities of racial injustice...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...